Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behçet's disease

Rheumatology International

Volumn 25, Issue 3, 2005, Pages 234-237

  Han, Seung Woo ^a   Kim, Gun Woo ^a   Lee, Jongmin ^a   Kim, Yong Joo ^a   Kang, Young Mo ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Beh et's disease; Budd Chiari syndrome; Percutaneous transluminal angioplasty

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; ASCITES; BEHCET DISEASE; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; LIVER VEIN THROMBOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME; ANGIOGRAPHY; FOLLOW UP; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RISK ASSESSMENT; VASCULAR PATENCY;

ANGIOGRAPHY; ANGIOPLASTY, BALLOON; BEHCET SYNDROME; FOLLOW-UP STUDIES; HEPATIC VEIN THROMBOSIS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 17744367807     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0495-4     Document Type: Article

References (15)

1. Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res 105:125-133
2. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenterol 92:858-862
3. Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8:223-260
4. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, Pichlmayr R (1995) Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 21:1337-1344
5. Slakey DP, Klein AS, Venbrux AC, Cameron JL (2001) Budd-Chiari syndrome: current management options. Ann Surg 233:522-527
6. Pelage JP, Denys A, Valla D, Sibert A, Sauvanet A, Belghiti J, Menu Y (2003) Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol 13:286-293
7. Cakaloglu Y, Okten A, Yalcin S (1991) Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients. Gastroenterology 100:1484-1485
8. Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E (1999) Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44:568-574
9. Hendrick RE (1987) Sampling time effects on signal-to-noise and contrast-to-noise ratios in spin-echo MRI. Magn Reson Imaging 5:31-37
10. Wu T, Wang L, Xiao Q, Wang B, Li S, Li X, Zhang J (2002) Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 83:175-178
11. Townsend (2001) Anatomy and development of liver. In: Sabiston textbook of surgery. Saunders, Phladelphia, pp 1002-1003
12. O'Duffy JD (1990) Vasculitis in Behçet's disease. Rheum Dis Clin North Am 16:423-431
13. Ozoran K, Dugun N, Gurler A, Tutkak H, Tokgoz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 24:376-382
14. Haznedaroglu IC, Ozdemir O, Ozcebe O, Dundar SV, Kirazli S (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75:974-975
15. Aydintug AO, Tokgoz G, D'Cruz DP, Gurler A, Cervera R, Duzgun N, Atmaca LS, Khamashta MA, Hughes GR (1993) Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 67:157-162